Bank Of America Corp Immunity Bio, Inc. Put Options Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $37,800 - $68,800	20,000 New	20,000 $52,000
Q4 2024 Feb 14, 2025	BUY	$2.56 - $6.17 $486,400 - $1.17 Million	190,000 New	190,000 $486,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $409,700 - $777,750	85,000 Added 32.08%	350,000 $2.21 Million
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $855,950 - $1.64 Million	265,000 New	265,000 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $22,338 - $93,586	14,600 New	14,600 $40,000
Q4 2022 Feb 10, 2023	BUY	$4.35 - $6.77 $39,150 - $60,929	9,000 New	9,000 $45,000

264

89.3M

1.2M

1.71M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $989M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.